The latest financial statement is for the quarter ending 2025-09-30.
| Cash Flow | 2025-09-30 | 2025-06-30 | 2024-12-31 |
|---|---|---|---|
| Net income | 352,019 | 609,632 | 2,552,215 |
| Interest earned on cash held in trust | 482,171 | 1,064,650 | 3,617,001 |
| Prepaid expenses | -20,531 | 40,324 | 2,176 |
| Formation costs paid by sponsor under promissory note related party | - | - | 0 |
| Due to a related company | -30,000 | -60,000 | -120,000 |
| Accrued expenses | -16,488 | 9,583 | 274,673 |
| Net cash used in operating activities | -96,109 | -425,759 | -672,289 |
| Cash withdrawn from trust account in connection to redemption | 0 | 31,265,500 | - |
| Extension payments deposited in trust account | 450,000 | 927,700 | 277,700 |
| Investment of cash in trust account | - | - | 0 |
| Net cash provided by investing activities | -450,000 | 30,337,800 | -277,700 |
| Repayment of promissory note related party | - | - | 0 |
| Proceeds from promissory note related party | - | - | 0 |
| Proceeds from extension promissory note related party | 450,000 | 927,700 | 277,700 |
| Proceeds from sale of units through public offering | - | - | 0 |
| Proceeds from sale of private placement units | - | - | 0 |
| Proceeds from issuance of ordinary shares to sponsor | - | - | 0 |
| Payment of offering costs | - | - | 0 |
| Advance from related party | 96,950 | 399,689 | 119,780 |
| Redemption of ordinary shares | 0 | 31,265,500 | - |
| Net cash used in financing activities | 546,950 | -29,938,111 | 397,480 |
| Net change in cash | 841 | -26,070 | -552,509 |
| Cash and cash equivalents at beginning of period | 28,208 | - | - |
| Cash and cash equivalents at end of period | 2,979 | - | - |
Aimei Health Technology Co., Ltd. (AFJK)
Aimei Health Technology Co., Ltd. (AFJK)